BIO在国会山发布行动方案BioAdvance,旨在确保美国继续引领全球生物技术,总裁兼CEO John F. Crowley与两党生物技术核心小组联合主席Rep. Houlahan共同出席。BIO援引《纽约时报》报道称中国正迅速缩小差距,美国生物技术领导地位不能被视为理所当然。BioAdvance为患者、美国经济与国家安全规划前进路径。
Last week on Capitol Hill, BIO launched BioAdvance, our action plan to ensure the United States continues to lead the world in biotechnology. BIO President and CEO John F. Crowley was joined by Rep. @HoulahanForPa, co-chair of the bipartisan Biotech Caucus. As the @NYTimes reported this week, China is rapidly closing the gap, and U.S. biotech leadership cannot be taken for granted. BioAdvance charts a path forward, for patients and for America's economy and national security.
Explore BioAdvance: http://bio.org/bioadvance
Read the New York Times article: https://www.nytimes.com/2026/11/17/science/fearing-chinese-rivals-us-biotech-adopts-a-new-norm-share-nothing.html
来源:Biotechnology Innovation Organization · x.com